Skip to main content

Table 4 The average annual exacerbations treatment cost

From: Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland

 

Unit Cost (EUR)

At entry

Week 52

Patients (n = 85)

Per patient

Patients (n = 85)

Per patient

No of exacerbations

EUR

No of exacerbations

EUR

No of exacerbations

EUR

No of exacerbations

EUR

Physician office visits

8.4

421

14,735.00

4.9529

173.35

157

5495.00

1.8471

64.65

Hospitalizations in Intensive Care Unit (ICU)

719.4

11

12,679.59

0.1294

149.17

0

0.00

0

0.00

ED visits

719.4

57

65,703.33

0.9706

772.98

13

14,984.97

0.1529

176.29

Hospitalizations (all but ICU)

611.0

75

191,100.00

0.8824

2248.24

22

56,056.00

0.2588

659.48